-
Dean Y. Maeda, PhD
-Management of preclinical development programs; >10 years with company
PhD (Pharmaceutical Chemistry) from Oregon State University0 -
Stuart Kahn, MD
-Clinical trial management; >10 years with company
MD from University of Medicine and Dentistry of New Jersey -
John A. Zebala, MD, PhD
-MD and PhD (Molecular Biology) from Weill Cornell Medical School. Syntrix founder and architect of the company and its development strategy.